AP2296A - Hydrochloride of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile. - Google Patents

Hydrochloride of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile.

Info

Publication number: AP2296A
Authority: AP; ARIPO
Prior art keywords: amino; cyanoethenyl; benzonitrile; dimethylphenyl; pyrimidinyl
Prior art date: 2004-09-02

Application number

AP2007003934A

Other languages

English (en)

Other versions

AP2007003934A0 (en

Inventor

Paul Theodoor Agnes Stevens

Jozef Peeters

Roger Petrus Gerebern Vandecruys

Original Assignee

Janssen Pharmaceutica Nv

Tibotec Pharm Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-09-02

Filing date

2005-09-02

Publication date

2011-10-31

2004-09-02 Priority claimed from MYPI20043578A external-priority patent/MY169670A/en

2005-09-02 Application filed by Janssen Pharmaceutica Nv, Tibotec Pharm Ltd filed Critical Janssen Pharmaceutica Nv

2005-09-02 Priority claimed from PCT/EP2005/054342 external-priority patent/WO2006024668A1/en

2007-04-30 Publication of AP2007003934A0 publication Critical patent/AP2007003934A0/xx

2011-10-31 Application granted granted Critical

2011-10-31 Publication of AP2296A publication Critical patent/AP2296A/xx

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
MYPI20043578A MY169670A (en)	2003-09-03	2004-09-02	Combinations of a pyrimidine containing nnrti with rt inhibitors
PCT/EP2005/054342 WO2006024668A1 (en)	2004-09-02	2005-09-02	Hydrochloride of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl] amino]benzonitrile

Publications (2)

Publication Number	Publication Date
AP2007003934A0 AP2007003934A0 (en)	2007-04-30
AP2296A true AP2296A (en)	2011-10-31

Family

ID=38137294

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AP2007003934A AP2296A (en)	2004-09-02	2005-09-02	Hydrochloride of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile.

Country Status (6)

Country	Link
CN (2)	CN101068597B (xx)
AP (1)	AP2296A (xx)
CR (1)	CR9031A (xx)
SG (1)	SG155885A1 (xx)
UA (2)	UA92469C2 (xx)
ZA (1)	ZA200701826B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN103420920B (zh) *	2012-05-14	2016-04-27	上海迪赛诺药业有限公司	利匹韦林盐酸盐醇化物多晶型物及其制备方法
WO2013170421A1 (zh) *	2012-05-14	2013-11-21	上海迪赛诺药业有限公司	利匹韦林盐酸盐醇化物多晶型物及其制备方法
CN110191704A (zh) *	2016-10-24	2019-08-30	爱尔兰詹森科学公司	可分散组合物

Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2003016306A1 (en) *	2001-08-13	2003-02-27	Janssen Pharmaceutica N.V.	Hiv inhibiting pyrimidines derivatives
WO2004016581A1 (en) *	2002-08-09	2004-02-26	Janssen Pharmaceutica N.V.	Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
WO2005021001A1 (en) *	2003-09-03	2005-03-10	Tibotec Pharmaceuticals Ltd.	Combinations of a pyrimidine containing nnrti with rt inhibitors

2005
- 2005-09-02 UA UAA200702178A patent/UA92469C2/ru unknown
- 2005-09-02 CN CN2005800380936A patent/CN101068597B/zh not_active Expired - Lifetime
- 2005-09-02 UA UAA200701971A patent/UA92467C2/ru unknown
- 2005-09-02 CN CNA200580038025XA patent/CN101056673A/zh active Pending
- 2005-09-02 SG SG200905799-3A patent/SG155885A1/en unknown
- 2005-09-02 AP AP2007003934A patent/AP2296A/xx active
2007
- 2007-03-01 ZA ZA200701826A patent/ZA200701826B/en unknown
- 2007-03-30 CR CR9031A patent/CR9031A/es not_active Application Discontinuation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2003016306A1 (en) *	2001-08-13	2003-02-27	Janssen Pharmaceutica N.V.	Hiv inhibiting pyrimidines derivatives
WO2004016581A1 (en) *	2002-08-09	2004-02-26	Janssen Pharmaceutica N.V.	Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
WO2005021001A1 (en) *	2003-09-03	2005-03-10	Tibotec Pharmaceuticals Ltd.	Combinations of a pyrimidine containing nnrti with rt inhibitors

Also Published As

Publication number	Publication date
AP2007003934A0 (en)	2007-04-30
UA92467C2 (xx)	2010-11-10
CN101056673A (zh)	2007-10-17
CN101068597A (zh)	2007-11-07
UA92469C2 (xx)	2010-11-10
ZA200701826B (en)	2008-07-30
SG155885A1 (en)	2009-10-29
CN101068597B (zh)	2012-04-18
CR9031A (es)	2009-01-16

Similar Documents

Publication	Publication Date	Title
FR16C1023I2 (fr)	2025-11-21	Sel de 4-[[4-[[4-(2-Cyanoethenyl)-2,6-dimethylphenyl]amino]-2-Pyrimidinyl]amino]benzonitrile
PL373679A1 (en)	2005-09-05	Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
IL202363A0 (en)	2010-06-30	Crystalline form of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
NO2014031I1 (no)	2015-01-05	(E)-4-[[4-[[4-(2-cyanoetenyl)-2,6-dimetylfenyl]amino-2-pyrimidinyl]-amino]-benzonitril (Rilpivirie) samt enhver terapeutisk ekvivalent form derav som er beskyttet av det aktuelle patentet så som farmasøytisk akseptable salter av Rilpiverine innbefattende hydrokloridsaltet av Rilpivirine, og Temofovir disproksil (spesielt Tenofovir disproksil fumaratsalt).
PL1632232T6 (pl)	2022-06-27	Sól 4-[[4-[[4-(2-cyjanoetenylo)-2,6-dimetylofenylo]amino]-2-pirymidynylo]amino]benzonitrylu
AP2296A (en)	2011-10-31	Hydrochloride of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile.
AP2487A (en)	2012-10-03	Fumarate of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]-amino]-2-pyrimidinyl]amino]benzonitrile
IL181649A0 (en)	2007-07-04	Furamate of 4-((4-((4-(2-cyanoethenyl)-2,6-dimethylphenyl)amino)-2-pyrimidinyl)amino) benzonitrile
WO2005113526A3 (en)	2006-06-15	Metabolites of 4-(3,4-dichloro-phenyl)-2-[2-(4-methyl-piperazin-1-yl)-benzylidene]-thiomorpholin-3-one